Navigation Links
ThermoGenesis Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
Date:9/21/2009

(R) AutoXpress(TM) Platform (AXP), a proprietary family of automated devices that includes the AXP and the MXP(TM) MarrowXpress and companion sterile blood processing disposables for harvesting stem cells in closed systems. The AXP device is used for the processing of cord blood. GE Healthcare is the exclusive global distribution partner for the AXP cord blood product except for Central and South America, China (except Hong Kong), Russia/CIS and Japan, where ThermoGenesis markets through independent distributors. The MXP is used for isolating stem cells from bone marrow.
  • The Res-Q(TM) 60 BMC (Res-Q), a point of care system that is designed for bone marrow stem cell processing. This product was launched in July 2009.
  • The CryoSeal((R) )FS System, an automated device and companion sterile blood processing disposable, is used to prepare fibrin sealants from plasma in about an hour. The CryoSeal FS System is approved in the U.S. for liver resection surgeries. The CryoSeal FS System has received the CE-Mark which allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in Japan and the Company markets through independent distributors in Europe and South America.
  • This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products
    '/>"/>

    SOURCE ThermoGenesis Corp.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results
    2. ThermoGenesis Announces Expanded Collaboration With Celling Technologies
    3. ThermoGenesis Provides Update on Fiscal 2009 Results
    4. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
    5. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
    6. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
    7. ThermoGenesis Presentation at Rodman & Renshaw Conference
    8. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
    9. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
    10. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
    11. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/4b8vj2/injectable_drug ) has announced the addition of ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics [Diabetes ... report to their offering. ...
    (Date:6/18/2013)... 2013 As a leading provider ... announces the release of their infographic - " ... , MeMD's goal was to leverage an information ... 2.0, Health 3.0 and mHealth.The infographic features a ... care and the fitness industry in unimaginable ways; ...
    (Date:6/18/2013)... Seattle, WA (PRWEB) June 18, 2013 Though ... May -- 11,000, according to the U.S. Bureau of Labor ... average increase of 24,000 per month. Most new health care ... while the hospital sector saw a loss of 6,000 jobs. ... Global outplacement consultancy firm Challenger, Gray & Christmas reported that ...
    (Date:6/18/2013)... 2013 New user friendly innovations in ... prevent the dangers of misuse and ineffective sterilization. ... pressure gauges, hot surfaces and complex door latches. ... modern autoclave, Revolutionary Science explains some important points to ... autoclave designs will recycle dirty water. This method ...
    Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
    ... 31 Savient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... and Drug Administration (FDA) seeking approval to,market pegloticase in ... review. Savient,s filing includes data from both the six-month,placebo ... from the Open,Label Extension (OLE) study. The data set ...
    ... 31 /Xinhua-PRNewswire/ -- Sundia MediTech,Company, a Shanghai-based drug ... this year,s Deloitte Technology,Fast 50 China award, and ... 50 China Program was announced today in Shenzhen, ... 50 Program started in 1995 in San Jose. ...
    ... than a dozen employers in health care, employment continued to increase in ... like no one was searching for those new jobs. , ... Seattle, ... care field, with an average of 30,000 jobs created each month. Even ...
    Cached Biology Technology:Savient Submits Biologics License Application (BLA) for pegloticase 2Savient Submits Biologics License Application (BLA) for pegloticase 3Savient Submits Biologics License Application (BLA) for pegloticase 4Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3
    (Date:6/17/2013)... As mobile devices, smartphones and tablets ... grows exponentially, and biometric authentication offers that security, ... Reading Insider ( www.heavyreading.com/mobile-networks ), a subscription ... www.heavyreading.com ). Biometrics Offer Promise for ... authentication on smartphones, analyzing the most lucrative verticals ...
    (Date:6/17/2013)... (June 17, 2013) The AGA Research Foundation and ... the future of gastroenterology with the 2013 AGA-Horizon Pharma ... Abstract Prizes. , "In its third year, this competition ... are embarking on promising careers in basic and clinical ... the AGA Research Foundation. "We are extremely proud of ...
    (Date:6/17/2013)... release is available in French . ... pathology in older mice with Alzheimer,s disease can be reversed ... Institute and Hospital - The Neuro, at McGill University and ... a specific receptor in the brain of mice with advanced ... published in the Journal of Neuroinflammation in May, ...
    Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3Horizon Pharma Abstract Prizes recognize promising fellows and students 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
    ... April 14, 2011 -- The number of couples struggling with ... assisted reproductive technologies, like in vitro fertilization (IVF), to get ... increase the risk of multiple pregnancies (i.e., twins or triplets), ... Twins and triplets are likely to be born prematurely, ...
    ... 2011 Ceelox, Inc. (OTCBB: CELO) announced today that ... to cloud applications using biometrics. Ceelox ID Online® utilizes ... an Internet server-based biometric software application. This enables users ... credentials, i.e. user name and password, compromised or stolen ...
    ... The following highlights summarize research papers that have been ... 1. Little Ice Age resulted from more than just ... measure of the amount of light the Sun puts out, ... especially when TSI is notably higher or lower than its ...
    Cached Biology News:New study finds stronger regulations of in vitro fertilization may save lives 2Ceelox Provides Biometric Identity Access to Cloud Applications 2Ceelox Provides Biometric Identity Access to Cloud Applications 3AGU journal highlights -- April 13, 2011 2AGU journal highlights -- April 13, 2011 3AGU journal highlights -- April 13, 2011 4AGU journal highlights -- April 13, 2011 5AGU journal highlights -- April 13, 2011 6AGU journal highlights -- April 13, 2011 7
    ...
    BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
    ... are designed for sequencing inserts cloned into ... or T3 RNA polymerase promoters, or lambda ... at a concentration of 0.1 µg/µl in ... DNA sequencing reactions using SequiTherm™ EXCEL™ II ...
    BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...
    Biology Products: